Literature DB >> 2441363

The NASPE/BPEG generic pacemaker code for antibradyarrhythmia and adaptive-rate pacing and antitachyarrhythmia devices.

A D Bernstein, A J Camm, R D Fletcher, R D Gold, A F Rickards, N P Smyth, S R Spielman, R Sutton.   

Abstract

A new generic pacemaker code, derived from and compatible with the Revised ICHD Code, was proposed jointly by the North American Society of Pacing and Electrophysiology (NASPE) Mode Code Committee and the British Pacing and Electrophysiology Group (BPEG), and has been adopted by the NASPE Board of Trustees. It is abbreviated as the NBG (for "NASPE/BPEG Generic") Code, and was developed to permit extension of the generic-code concept to pacemakers whose escape rate is continuously controlled by monitoring some physiologic variable, rather than determined by fixed escape intervals measured from stimuli or sensed depolarizations, and to antitachyarrhythmia devices including cardioverters and defibrillators. The NASPE/BPEG Code incorporates an "R" in the fourth position to signify rate modulation (adaptive-rate pacing), and one of four letters in the fifth position to indicate the presence of antitachyarrhythmia-pacing capability or of cardioversion or defibrillation functions.

Mesh:

Year:  1987        PMID: 2441363     DOI: 10.1111/j.1540-8159.1987.tb06035.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  16 in total

Review 1.  Is VVI pacing outmoded?

Authors:  A W Nathan; D W Davies
Journal:  Br Heart J       Date:  1992-04

2.  Pacemakers in children: medical and surgical aspects.

Authors:  R A Friedman
Journal:  Tex Heart Inst J       Date:  1992

3.  Experimental study on malfunction of pacemakers due to exposure to different external magnetic fields.

Authors:  Maria Tiikkaja; Tommi Alanko; Harri Lindholm; Maila Hietanen; Juha Hartikainen; Lauri Toivonen
Journal:  J Interv Card Electrophysiol       Date:  2012-01-11       Impact factor: 1.900

Review 4.  Pacing for drug-refractory or drug-intolerant hypertrophic cardiomyopathy.

Authors:  Mohammed Qintar; Abdulrahman Morad; Hazem Alhawasli; Khaled Shorbaji; Belal Firwana; Adib Essali; Waleed Kadro
Journal:  Cochrane Database Syst Rev       Date:  2012-05-16

Review 5.  New concepts in physiologic cardiac pacing.

Authors:  Dwight W Reynolds; Christina M Murray
Journal:  Curr Cardiol Rep       Date:  2007-09       Impact factor: 2.931

6.  Recommendations for pacemaker prescription for symptomatic bradycardia. Report of a working party of the British Pacing and Electrophysiology Group.

Authors: 
Journal:  Br Heart J       Date:  1991-08

7.  Permanent pacemaker insertion in a district general hospital: indications, patient characteristics, and complications.

Authors:  A Eltrafi; P Currie; J H Silas
Journal:  Postgrad Med J       Date:  2000-06       Impact factor: 2.401

Review 8.  Coronary artery disease, valvular heart disease, bradycardia, and heart failure.

Authors:  E Smith; H Powell; I R Hastie
Journal:  Postgrad Med J       Date:  1995-06       Impact factor: 2.401

9.  [Advanced classification for cardiovascular devices].

Authors:  Andreas Schuchert
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2016-12

10.  Cardiac pacing for bradyarrhythmias in the elderly.

Authors:  R Sutton
Journal:  J R Soc Med       Date:  1994-04       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.